[Congressional Bills 118th Congress]
[From the U.S. Government Publishing Office]
[S. Res. 757 Agreed to Senate (ATS)]

<DOC>






118th CONGRESS
  2d Session
S. RES. 757

Designating the week of May 5, 2024, through May 11, 2024, as ``Tardive 
                      Dyskinesia Awareness Week''.


_______________________________________________________________________


                   IN THE SENATE OF THE UNITED STATES

                              July 9, 2024

Mr. Mullin submitted the following resolution; which was considered and 
                               agreed to

_______________________________________________________________________

                               RESOLUTION


 
Designating the week of May 5, 2024, through May 11, 2024, as ``Tardive 
                      Dyskinesia Awareness Week''.

Whereas many people living with serious mental illnesses, including bipolar 
        disorder, major depressive disorder, schizophrenia, and schizoaffective 
        disorder, or gastrointestinal disorders and symptoms, including 
        gastroparesis, upset stomach, nausea, and vomiting, may be treated with 
        medications that work as dopamine receptor blocking agents, such as 
        antipsychotics and antiemetics;
Whereas, while ongoing treatment with medications can be necessary for serious 
        mental illnesses or gastrointestinal disorders, prolonged use of 
        medications is associated with tardive dyskinesia (referred to in this 
        preamble as ``TD'');
Whereas TD is an involuntary movement disorder that is characterized by 
        uncontrollable, abnormal, and repetitive movements of the face, torso, 
        limbs, and fingers or toes;
Whereas even mild symptoms of TD can impact an individual physically, socially, 
        and emotionally;
Whereas TD affects approximately 600,000 individuals in the United States and 
        approximately 65 percent of individuals with TD have not been diagnosed, 
        making it important to raise awareness about the symptoms;
Whereas it is important and recommended by the American Psychiatric Association 
        that individuals taking medications be monitored for TD by a health care 
        provider;
Whereas clinical research has led to approval of treatments for adults with TD 
        by the Food and Drug Administration;
Whereas recognition and treatment of TD can make a positive impact in the lives 
        of many individuals experiencing psychotic and mood disorders; and
Whereas the Senate can raise awareness of TD among the public and medical 
        community: Now, therefore, be it
    Resolved, That the Senate--
            (1) expresses support for the designation of May 5, 2024, 
        through May 11, 2024, as ``Tardive Dyskinesia Awareness Week'';
            (2) encourages each individual in the United States to 
        become better informed about and aware of Tardive Dyskinesia; 
        and
            (3) encourages individuals experiencing uncontrollable, 
        abnormal, and repetitive movements to consult a health care 
        provider regarding their symptoms.
                                 <all>